Medpace.com::Importance of Vendor Setup and Synchronization at the Start of the Trial

Importance of Vendor Setup and Synchronization at the Start of the Trial

Jennifer Haggard, Director, Clinical Operations, Europe, Medpace, CRO

Jennifer A. Haggard, MS
Director, Clinical Operations, Europe

Jennifer Haggard is a Clinical Trial Manager at Medpace, based in the Munich office. Jennifer has experience managing global trials, consisting of complicated oncology studies (including solid tumor lung) and large multi-national studies. These studies have included sites in all regions of the world, including, Europe, North America, Asia, and Latin America. She received a Master of Health Science in Clinical Research Administration degree from The George Washington University in Washington, DC.

Additional Information

Leveraging decades of Phase I-IV experience in multiple therapeutic areas of drug development and our deep understanding of how to accelerate your drug towards approval, our therapeutic and regulatory experts excel at streamlining your trial process and delivering solutions focused on the critical needs of your study.